Two Sigma Advisers
QTTB icon

Two Sigma Advisers’s Q32 Bio QTTB Stock Holding History

Two Sigma Advisers’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,100
Closed -$72K – 2934
2021
Q4 		$72K Sell
1,100
-389
-26% -$37.8K ﹤0.01% 2446
2021
Q3 		$211K Buy
+1,489
New +$190K ﹤0.01% 2232
2020
Q4 		– Sell
-1,056
Closed -$203K – 2631
2020
Q3 		$203K Sell
1,056
-450
-30% -$101K ﹤0.01% 2153
2020
Q2 		$412K Sell
1,506
-16
-1% -$4.26K ﹤0.01% 1983
2020
Q1 		$426K Buy
+1,522
New +$466K ﹤0.01% 1867

Other funds holding QTTB

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return

Two Sigma Advisers's QTTB Position: Q1 2022 in Review

Two Sigma Advisers sold out of Q32 Bio (QTTB) in Q1 2022, closing a stake of 1,100 shares — an estimated $72K sold.

Two Sigma Advisers first reported a position in QTTB in Q1 2020 and held it in 5 quarters. The position peaked at $426K in Q1 2020. 106 funds tracked by Wall St. Rank hold QTTB as of Q1 2022.

  • Two Sigma Advisers reported no remaining Q32 Bio position as of Q1 2022 after selling out during the quarter.
  • Two Sigma Advisers sold 1,100 Q32 Bio shares in Q1 2022, an estimated $72K.
  • Two Sigma Advisers first reported a position in Q32 Bio in Q1 2020 and held it in 5 quarters.
  • Two Sigma Advisers's Q32 Bio position peaked at $426K in Q1 2020.
  • 106 funds tracked by Wall St. Rank held Q32 Bio as of Q1 2022.

Based on Two Sigma Advisers's 13F filing for Q1 2022, filed 16 May 2022.